News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
24 June 2021
Avance Clinical Announces Appointment of Asia Biotech Specialist to Support APAC Growth
The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region.
20 June 2021
Avance Clinical’s USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities
Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021.
10 June 2021
TrialTrove Data Shows Australia is Open for Business says Avance Clinical at BIO Digital 2020
The leading Australian CRO for biotechs, Avance Clinical announced at BIO Digital today that Australia currently has 2,413 trials planned or ongoing.
21 May 2021
Avance Clinical Wins Excellence in Business Award 2021
Avance Clinical has won the Fast Movers SA Excellence in Business Award 2021 sponsored by international accounting and business advisory firm BDO.
Proven industry
experience & expertise
800+
Studies in the past 10 years
500+
Experienced team members
33k+
Participants past 10 years
30
Years of CRO experience